Objective To observe application of permanent pacemaker implantation in children with atrial ventricular block.
目的观察永久心脏起搏器在儿童病例中的应用及疗效。
Conclusions Anti-atrial fibrillation pacemaker in the treatment of PAF is superior than conventional DDD pacing and may be important complementation of traditional methods .
结论抗房颤起搏器治疗阵发房颤优于普通DDD起搏器，似可作为传统治疗方法的重要补充。
MedWire News: Statin treatment may help to prevent atrial fibrillation (AF) recurrence, suggests an observational study of patients implanted with a pacemaker.
医学在线新闻：他汀类药物治疗可能有助于预防心房颤动(AF)复发，一项对植入起搏器患者的观察性研究显示。
Conclusion: Amiodarone can suppress the incidence of atrial fibrillation obviously after VVI pacemaker implantation.
结论胺碘酮对植入VV I型起搏器患者心房颤动的发生有明显的抑制作用。
Objective to evaluate the safety and efficacy of the procedure with atrioventricular node ablation and pacemaker implantation in patients with refractory atrial flutter and atrial fibrillation.
目的评价房室结消融加永久起搏器植入治疗难治性房扑房颤的安全性和有效性。
Objective to inquire into the forward clinical results of ventricular pacing, dual-chamber sensing, atrial-triggered, and ventricular-inhibited (VDD) Pacemaker in an unipolar lead.
目的探讨单根电极导线心室起搏双腔感知双反应方式起搏器(VDD起搏器)的远期临床使用效果。
Atrial fibrillation (Af) is the most commonly cardiac arrhythmia except premature ventricular beats. The therapy of Af with pacemaker is a valid method to the chronic and stubborn Af now.
心房颤动是室性早博后第二位的心律失常，起搏治疗心房颤动目前已成为难治性心房颤动的有效治疗途径。
Statin treatment may help to prevent atrial fibrillation (AF) recurrence, suggests an observational study of patients implanted with a pacemaker.
他汀类药物治疗可能有助于预防心房颤动（AF）复发，一项对植入起搏器患者的观察性研究显示。
Results Patients were followed up for 6 months, and no pacemaker-associated atrial and ventricular arrhythmias and other adverse events were observed.
结果在6个月的随访中，所有患者未观察到与起搏器相关的房性和室性心律失常及其他不良反应事件。
Results Patients were followed up for 6 months, and no pacemaker-associated atrial and ventricular arrhythmias and other adverse events were observed.
结果在6个月的随访中，所有患者未观察到与起搏器相关的房性和室性心律失常及其他不良反应事件。
应用推荐